Cdc27 Antibodies

Santa Cruz Biotechnology delivers a wide array of Cdc27 monoclonal antibodies for research in cell cycle regulation and mitotic processes. Cdc27 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). Cdc27, a crucial component of the anaphase-promoting complex/cyclosome (APC/C), plays a significant role in the regulation of the cell cycle by mediating the degradation of cell cycle proteins. Proper Cdc27 function is essential for the timely progression through mitosis, and Cdc27 dysregulation has been implicated in various cancers. Understanding Cdc27's role in cellular processes continues to be a focus of intense research worldwide. Investigating Cdc27 function and regulation provides valuable insights into cell cycle control mechanisms. Current research explores how Cdc27 activity influences cancer development and progression. Ongoing studies examine potential therapeutic approaches targeting Cdc27-mediated pathways. Santa Cruz Biotechnology monoclonal antibodies enable researchers to advance scientific understanding of cell cycle regulation and its impact on human health.